Literature DB >> 29877290

Combined Abducens and Peripheral Facial Nerve Palsy.

Kazuto Tsukita1,2, Haruhi Sakamaki-Tsukita1, Toshihiko Suenaga1.   

Abstract

Entities:  

Keywords:  abducens nerve palsy; acute ischemic stroke; peripheral facial nerve palsy; the pons

Year:  2018        PMID: 29877290      PMCID: PMC6262706          DOI: 10.2169/internalmedicine.1139-18

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
A 49-year-old man with diabetes mellitus presented with a sudden-onset of horizontal diplopia followed by left facial weakness a day after this onset. A physical examination revealed impaired left eye abduction and difficulties closing the left eye, raising the left eyebrow, and lifting the left corner of the mouth, which suggested combined left abducens and peripheral facial nerve palsy. On admission, head computed tomography did not reveal any lesions. However, brain magnetic resonance imaging (MRI) revealed a linear hyperintense lesion in the left pons with decreased apparent diffusion coefficient values on diffusion-weighted imaging, suggesting acute ischemic stroke (Picture). Treatment with anti-platelet and lipid-lowering drugs resolved the symptoms completely in three months. The combination of abducens and peripheral facial nerve palsy strongly indicates a lesion in the pons, since the abducens and facial nerves run close together there (Picture) (1,2). The prompt and detailed investigation of a pontine lesion including MRI is crucial for achieving a good outcome.
Picture.
The authors state that they have no Conflict of Interest (COI).
  2 in total

1.  Neurological picture. Concomitant sixth nerve and seventh nerve palsies.

Authors:  Aileen A Antonio-Santos; Eric R Eggenberger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-05       Impact factor: 10.154

2.  Combined peripheral facial and abducens nerve palsy caused by caudal tegmental pontine infarction.

Authors:  J K Roh; B K Kim; J M Chung
Journal:  Eur Neurol       Date:  1999       Impact factor: 1.710

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.